The lack of 4-hydroxynonenal in otosclerotic bone tissue in Ethiopian population
- 127 Downloads
In Ethiopians, like in other Africans, the incidence of otosclerosis is lower than in Western and Asian populations. Unfortunately, due to the lack of available otorhinolaryngology specialists many patients are not treated and suffer the progression of the disease and severe hearing loss. This program of the Global ENT Outreach Organization (GEO) together with the Ethiopian partners was done to help some of these patients and in parallel to evaluate the presence of the oxidative stress bioactive marker 4-hydroxynonenal (HNE), which is known as major lipid peroxidation product and the second messenger of free radicals, in the otosclerotic bone specimens. Namely, we described recently that as HNE acts as a bone growth regulator associated with pathogenesis of otosclerosis. The prospective study conducted at the ENT Department of the Migbare Senay General Hospital, Addis Ababa, Ethiopia in June 2012, under the auspices of the Global ENT Outreach Organization, USA. Altogether 36 patients (male = 12, female = 24) underwent surgery due to the previous otosclerosis diagnosis based on the clinical and audiometric findings. The bone samples were harvested from patients with intraoperatively confirmed otosclerosis diagnosis. Immunohistochemistry for HNE-modified proteins was carried out on formalin-fixed paraffin-embedded specimens. The presence of HNE was found in almost all bone samples analyzed, without particular difference in the HNE distribution pattern between the otosclerotic and respective control bone specimens. Although there was no significant association between the HNE appearance and otosclerotic bone outgrowth observed, several cases have shown tendency of higher HNE expression in patients with more severe hearing loss. The results of the present study are in contrast with our previous findings obtained on European patients most likely due to the differences between studied population groups.
KeywordsOxidative stress Otosclerosis Pathophysiology
Migbare Senay General Hospital staff (ENT surgery department and operating theater staff) The Department of Pathology and Forensic Medicine staff, General Hospital Zadar, Croatia and EU grants COST Action CM1001.
- 1.Donaldson JA, Snyder M (1993) Otosclerosis. In: Cummings CW, Frederickson JM, Harker LA, Krause CJ, Schuller DE (eds) Otolaryngology-head and neck surgery. Mosby-Year Book, St Louis, pp 2997–3016Google Scholar
- 2.Liktor B, Csomor P, Karosi T (2013) Detection of otosclerosis-specific Measles Virus receptor (Cd46) protein isoforms. ISRN OtolaryngolGoogle Scholar
- 3.Declau F, van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, van de Heyning P (2007) Prevalence of histologic otosclerosis: an unbiased temporal bone study in Caucasians. Adv Otorhinolaryngol 67:6–16Google Scholar
- 4.Chole RA, McKenna M (2001) Pathophysiology of otosclerosis. Otol Neurotol 22:49–257Google Scholar
- 5.Grayeli AB, Sterkers O, Roulleau P, Elbaz P, Ferrary E, Silve C (1999) Parathyroid hormone-parathyroid hormone related peptide receptor expression and function in otosclerosis. Am J Physiol 277:E10005–E11012Google Scholar
- 15.Rudić M, Milković L, Žarković K, Borović-Šunjić S, Sterkers O, Waeg G, Ferrary E, Bozorg Grayeli A, Žarković N (2013) The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis. Free Radic Biol Med 57:22–28CrossRefPubMedGoogle Scholar
- 27.Thys M, Schrauwen I, Vanderstraeten K, Janssens K, Dieltjens N, Van Den Bogaert Kris, Fransen E, Chen W, Ealy M, Claustres M, Cremers CRWJ, Dhooge I, Declau F, Claes J, Van de Heyning P, Vincent R, Somers T, Offeciers E, Smith RJH, Van Camp G (2007) The coding polymorphism T263I in TGF-b1 is associated with otosclerosis in two independent populations. Hum Mol Genet 16:2021–2030CrossRefPubMedGoogle Scholar
- 28.Tshifularo M, Joseph CA (2008) Otosclerosis and TGF-β1 gene in black South Africans. South African Med J 98:720–723Google Scholar
- 29.Bodo M, Venti G, Baroni T, Bellucci C, Giammarioli M, Donti E, Paludetti G, Stabellini G, Carinci P (1995) Phenotype of in vitro human otosclerotic cells and its modulation by TGF beta. Cel Mol Biol 1995(41):1039–1049Google Scholar
- 32.Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Manuel Otin P, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Richard RCM, Wiswedel I, Zarkovic K, Zarkovic N (2010) Pathological aspects of lipid peroxidation. Free Radic Res 44:1125–1171CrossRefPubMedGoogle Scholar